Welcome to cardiomed's virtual booth

Since 1978, CardioMed Supplies Inc., has been a leading Canadian manufacturer and distributor of disposable medical devices for open heart surgery, dialysis, critical care, oncology, and other specialized areas. CardioMed has earned a strong reputation for our innovative research and design, our use of high-quality materials, and our meticulous attention to the changing needs of today’s physicians, nurses, and patients.

In addition to our manufactured products, we also have partnered with leading American and European manufacturers to distribute a complete range of products which further complement our product lines.

INTRODUCING EUROSETS REMOWELL2
REMOWELL2 is designed to reduce neurological injury and inflammatory response in patients undergoing cardiac surgery, thanks to its unique and patented cardiotomy features capable to reduce lipids and leukocytes cells coming from pericardial suction blood. Literature evidenced the efficacious filtration by REMOWELL technology of LME (Lipid Micro Emboli) in the clinical setting and the subsequent attenuation of NSE release, a known marker of neurologic injury. In addition, a significantly lower concentration of cystatin C, a known biomarker of kidney function, was found in the postoperative period, suggesting a renoprotective role for LME filtration9. The Remowell filtration technology effectively contributes to reducing inflammatory response and minimizing the negative effects of cardiopulmonary bypass.

Evidence based strategies to optimize VAD
outcomes with COVID patients

PRODUCT SHOWCASE

Remowell2

REMOWELL2 is designed to reduce neurological injury and inflammatory response in Patients undergoing cardiac surgery, thanks to its unique and patented cardiotomy features capable to reduce lipids and leukocytes cells coming from pericardial suction blood. Literature evidenced the efficacious filtration by REMOWELL technology of LME (Lipid Micro Emboli) in the clinical setting and the subsequent attenuation of NSE release, a known marker of neurologic injury. In addition, significantly lower concentration of cystatin C, a known biomarker of kidney function, was found in the postoperative period, suggesting a renoprotective role for LME filtration9. The Remowell filtration technology, effectively contribute to reduce inflammatory response and minimize the negative effects of cardiopulmonary bypass.

Evidence-based strategies to enhance patient
safety during the challenges of COVID care

Contact one of our representatives for more information.

Todd Townend

Territory Account Manager: Ontario

Contact Todd Townend

Please feel free to contact Todd Townend directly by phone at:
(647) 981-0196
or by email clicking the button below.

Justin Dubé

Territory Account Manager: Eastern Ontario & Bermuda

Contact Justin Dube

Please feel free to contact Justin Dube directly by phone at:
(647) 567-6833
or by email clicking the button below.

CardioMed Supplies Inc.

199 St. David Street
Lindsay, ON, Canada
K9V-5K7
Phone: (705) 328-2518
Fax: (705) 328-9747
Toll-Free: 1-800-387-9757
Email: [email protected]

Nipro Canada – CardioMed Supplies Inc.

199 St. David Street
Lindsay, ON, Canada
K9V-5K7

Phone: (705) 328-2518
Fax: (705) 328-9747
Toll-Free: 1-800-387-9757
Email: [email protected]